Correlation Between MaxCyte and Cerus
Can any of the company-specific risk be diversified away by investing in both MaxCyte and Cerus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and Cerus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MaxCyte and Cerus, you can compare the effects of market volatilities on MaxCyte and Cerus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of Cerus. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and Cerus.
Diversification Opportunities for MaxCyte and Cerus
Weak diversification
The 3 months correlation between MaxCyte and Cerus is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and Cerus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerus and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with Cerus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerus has no effect on the direction of MaxCyte i.e., MaxCyte and Cerus go up and down completely randomly.
Pair Corralation between MaxCyte and Cerus
Given the investment horizon of 90 days MaxCyte is expected to generate 0.88 times more return on investment than Cerus. However, MaxCyte is 1.14 times less risky than Cerus. It trades about 0.04 of its potential returns per unit of risk. Cerus is currently generating about -0.02 per unit of risk. If you would invest 400.00 in MaxCyte on September 12, 2024 and sell it today you would earn a total of 19.00 from holding MaxCyte or generate 4.75% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
MaxCyte vs. Cerus
Performance |
Timeline |
MaxCyte |
Cerus |
MaxCyte and Cerus Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MaxCyte and Cerus
The main advantage of trading using opposite MaxCyte and Cerus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, Cerus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerus will offset losses from the drop in Cerus' long position.MaxCyte vs. Sight Sciences | MaxCyte vs. CVRx Inc | MaxCyte vs. Neuropace | MaxCyte vs. Rapid Micro Biosystems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |